Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2023 | Chronic GvHD following alloSCT requires a complex multi-specialist pathway

Daniele Avenoso • 20 Oct 2023
COSTEM 2023
General

In this video, Daniele Avenoso, MD, King’s College Hospital NHS Foundation Trust, London, UK, discusses a real-world study conducted in the UK evaluating the burden of chronic graft-versus-host disease (GvHD) in patients undergoing allogeneic stem cell transplantation (alloSCT). In this study, it was found that patients with chronic GvHD require assessments from various other specialists, including gastroenterologists and dermatologists, demonstrating the importance of multi-specialist pathways in the treatment and management of GvHD. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

This study was funded by Sanofi.

More from Daniele Avenoso

1:03
Reduced intensity vs myeloablative conditioning regimens in patients with AML and MDS
Daniele Avenoso • 20 Oct 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals